- Home
- NAAS vs CELZ Comparison
NAAS vs CELZ Comparison
Compare NAAS & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- CELZ
- Stock Information
- Founded
- NAAS 2019
- CELZ 1998
- Country
- NAAS China
- CELZ United States
- Employees
- NAAS N/A
- CELZ N/A
- Industry
- NAAS Other Specialty Stores
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- NAAS Consumer Discretionary
- CELZ Health Care
- Exchange
- NAAS Nasdaq
- CELZ Nasdaq
- Market Cap
- NAAS 8.3M
- CELZ 7.4M
- IPO Year
- NAAS 2017
- CELZ N/A
- Fundamental
- Price
- NAAS $3.84
- CELZ $3.63
- Analyst Decision
- NAAS
- CELZ
- Analyst Count
- NAAS 0
- CELZ 0
- Target Price
- NAAS N/A
- CELZ N/A
- AVG Volume (30 Days)
- NAAS 127.5K
- CELZ 34.2K
- Earning Date
- NAAS 09-05-2025
- CELZ 11-07-2025
- Dividend Yield
- NAAS N/A
- CELZ N/A
- EPS Growth
- NAAS N/A
- CELZ N/A
- EPS
- NAAS N/A
- CELZ N/A
- Revenue
- NAAS $27,534,354.00
- CELZ $6,000.00
- Revenue This Year
- NAAS $378.49
- CELZ N/A
- Revenue Next Year
- NAAS N/A
- CELZ N/A
- P/E Ratio
- NAAS N/A
- CELZ N/A
- Revenue Growth
- NAAS N/A
- CELZ N/A
- 52 Week Low
- NAAS $1.96
- CELZ $1.69
- 52 Week High
- NAAS $74.40
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- NAAS 66.08
- CELZ 64.58
- Support Level
- NAAS $2.69
- CELZ $3.39
- Resistance Level
- NAAS $3.33
- CELZ $3.74
- Average True Range (ATR)
- NAAS 0.31
- CELZ 0.15
- MACD
- NAAS 0.07
- CELZ 0.02
- Stochastic Oscillator
- NAAS 87.79
- CELZ 83.06
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.